Search research articles
Contact Us
Filters
Showing results (801-810 of 833) with videos related to
Page
of 84
Sort By:
Journal of Medicinal Chemistry
|
March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722
M Winn, T W von Geldern, T J Opgenorth, et al.
Emerging Infectious Diseases
|
May 13, 2025
Nationwide Implementation of HIV Molecular Cluster Detection by Centers for Disease Control and Prevention and State and Local Health Departments, United States
Anne Marie France, Camden J Hallmark, Nivedha Panneer, et al.
Genome Research
|
April 20, 1999
Genome-scale cloning and expression of individual open reading frames using topoisomerase I-mediated ligation
J A Heyman, J Cornthwaite, L Foncerrada, et al.
The American Journal of Clinical Nutrition
|
May 4, 2016
Alterations in human milk leptin and insulin are associated with early changes in the infant intestinal microbiome
Dominick J Lemas, Bridget E Young, Peter R Baker, et al.
Leukemia
|
September 26, 2013
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
E Clappier, M F Auclerc, J Rapion, et al.
The Journal of Allergy and Clinical Immunology
|
October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial
Jonathan Corren, David Larson, Matthew C Altman, et al.
Nature Communications
|
July 3, 2019
Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Taylor K Soderborg, Sarah E Clark, Christopher E Mulligan, et al.
Nature Communications
|
October 28, 2018
The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Taylor K Soderborg, Sarah E Clark, Christopher E Mulligan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2024
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
Charles N Landen, Ronald J Buckanovich, Michael W Sill, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 3, 2020
Multidisciplinary Community-Based Investigation of a COVID-19 Outbreak Among Marshallese and Hispanic/Latino Communities - Benton and Washington Counties, Arkansas, March-June 2020
Katherine E Center, Juliana Da Silva, Angela L Hernandez, et al.
Page
of 84
Search research articles
Search
Showing results (801-810 of 833) with videos related to
Sort By:
Page
of 84
Journal of Medicinal Chemistry
|
March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722
M Winn, T W von Geldern, T J Opgenorth, et al.
Emerging Infectious Diseases
|
May 13, 2025
Nationwide Implementation of HIV Molecular Cluster Detection by Centers for Disease Control and Prevention and State and Local Health Departments, United States
Anne Marie France, Camden J Hallmark, Nivedha Panneer, et al.
Genome Research
|
April 20, 1999
Genome-scale cloning and expression of individual open reading frames using topoisomerase I-mediated ligation
J A Heyman, J Cornthwaite, L Foncerrada, et al.
The American Journal of Clinical Nutrition
|
May 4, 2016
Alterations in human milk leptin and insulin are associated with early changes in the infant intestinal microbiome
Dominick J Lemas, Bridget E Young, Peter R Baker, et al.
Leukemia
|
September 26, 2013
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
E Clappier, M F Auclerc, J Rapion, et al.
The Journal of Allergy and Clinical Immunology
|
October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial
Jonathan Corren, David Larson, Matthew C Altman, et al.
Nature Communications
|
July 3, 2019
Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Taylor K Soderborg, Sarah E Clark, Christopher E Mulligan, et al.
Nature Communications
|
October 28, 2018
The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Taylor K Soderborg, Sarah E Clark, Christopher E Mulligan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2024
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
Charles N Landen, Ronald J Buckanovich, Michael W Sill, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 3, 2020
Multidisciplinary Community-Based Investigation of a COVID-19 Outbreak Among Marshallese and Hispanic/Latino Communities - Benton and Washington Counties, Arkansas, March-June 2020
Katherine E Center, Juliana Da Silva, Angela L Hernandez, et al.
Page
of 84